Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride

Journal of Association of Physicians of India

Volumn 54, Issue DEC., 2006, Pages 951-952

  Kesavadev, J ^a   Rasheed, S A ^a,b  

^a Jothydev's Diabetes and Research Center

^b Jothydev's Diabetes and Research Center ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GATIFLOXACIN; GLIMEPIRIDE; QUINOLONE DERIVATIVE; SULFONYLUREA DERIVATIVE;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MIDDLE AGED;

ANTI-INFECTIVE AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; FLUOROQUINOLONES; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MIDDLE AGED; SULFONYLUREA COMPOUNDS;

EID: 33947580657     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hosaka M. Antibacterial property and clinical effect of gatifloxacin, a novel quinolone antibacterial agent. Nippon Yakurigaku Zasshi 2003;121:447-56.
2. Khovidhunkit WSS. Hypoglycemia, hyperglycemia, and gatifloxacin. Ann Intern Med 2004;141:969.
3. Bhatia VBR, Dhindsa S. Gatifloxacin-induced hyperglycemia. Endocr Pract 2004;10:86.
4. Stephen D, Shafran M, FRCPC. Glucose Homeostasis Abnormalities and Fluoroquinolones: A Canadian Thought-Leader Perspective From Stephen D. Shafran, MD, FRCPC. In: Medscape HIV/AIDS. 2005.
5. Gavin JR III KR, Choudhri S, et al. Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies. Drug Saf 2004:671-86.
6. Stahlmann RL, Hartmut. Fluoroquinolones in the elderly: safety